RMR Wealth Builders’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,897
Closed -$328K 242
2023
Q3
$328K Sell
9,897
-447
-4% -$15.8K 0.05% 173
2023
Q2
$379K Buy
10,344
+176
+2% +$6.85K 0.06% 142
2023
Q1
$415K Buy
10,168
+43
+0.4% +$1.86K 0.08% 125
2022
Q4
$519K Sell
10,125
-545
-5% -$26.1K 0.12% 93
2022
Q3
$467K Buy
10,670
+1,556
+17% +$75.6K 0.11% 96
2022
Q2
$478K Buy
9,114
+91
+1% +$4.64K 0.12% 109
2022
Q1
$467K Buy
9,023
+797
+10% +$41.4K 0.1% 125
2021
Q4
$486K Sell
8,226
-2,857
-26% -$142K 0.14% 68
2021
Q3
$477K Buy
11,083
+1,948
+21% +$86.3K 0.14% 104
2021
Q2
$358K Sell
9,135
-4,374
-32% -$170K 0.12% 120
2021
Q1
$489K Buy
13,509
+6,894
+104% +$245K 0.13% 99
2020
Q4
$243K Sell
6,615
-14,483
-69% -$531K 0.12% 134
2020
Q3
$735K Buy
21,098
+18,188
+625% +$638K 0.19% 84
2020
Q2
$91K Buy
+2,910
New +$98.9K 0.08% 175
2019
Q4
$86K Buy
+2,319
New +$82.6K 0.08% 185

Other funds holding PFE

RMR Wealth Builders's PFE Position: Q4 2023 in Review

RMR Wealth Builders sold out of Pfizer (PFE) in Q4 2023, closing a stake of 9,897 shares — an estimated $328K sold.

RMR Wealth Builders first reported a position in PFE in Q4 2019 and held it in 15 quarters. The position peaked at $735K in Q3 2020. 2,940 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • RMR Wealth Builders reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • RMR Wealth Builders sold 9,897 Pfizer shares in Q4 2023, an estimated $328K.
  • RMR Wealth Builders first reported a position in Pfizer in Q4 2019 and held it in 15 quarters.
  • RMR Wealth Builders's Pfizer position peaked at $735K in Q3 2020.
  • 2,940 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on RMR Wealth Builders's 13F filing for Q4 2023, filed 6 Feb 2024.